Cardiatec is a medical technology company specializing in developing innovative solutions for cardiovascular health monitoring and management.

Cardiatec

Primordial AI utilizes evolutionary data and artificial intelligence to discover drug targets, focusing on achieving next-generation drug development.

Primordial AI

CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.

Laidlaw Scholars Ventures

O2h Ventures

APEX Ventures

Crista Galli Ventures

University of Cambridge Enterprise

CardiaTec Biosciences

🌟 Advisor Spotlight: Dr. Christopher Miller 🌟

We are thrilled to introduce Dr. Christopher Miller, a valued member of our Scientific Advisory Board. Chris brings a distinguished career spanning 30 years in applied genomics, functional genomics, and multi-omics, having contributed significantly at Bristol Myers Squibb, AbbVie, Pfizer, and GSK. Throughout his career, Chris has played a pivotal role in drug target identification, target validation, drug discovery, and development, translating results from human genetics into impactful drug discovery programs.

Welcome on board once again! 🚀

🌟 Spotlight 🌟

Thrilled to see our COO & Co-Founder, Thelma Zablocki, at the InspiringFifty Women In Tech Breakfast organised by EQL:HER & Founders Forum Group, alongside Meta. 🎉

#WomenInTech #Leadership #AIdrugdiscovery #EQLHER #FoundersForumGroup #Meta 

Exciting news! Our founders will be at the LSX Conference on November 13th. This is a chance to connect and explore CardiaTec Biosciences's ambitions and future prospects 🚀 

Link: https://lnkd.in/eE_QBbD 

Metric
Company Name	Cardiatec	Primordial AI
Symbol
MSH ID	AI:CARDIATEC	COM:PRIMORDIALBIO
Market	PRIVATE	PRIVATE
Sector	Medical Devices & Equipment	Healthcare & Health Services
Industry	Healthcare Technology	Biotechnology
Country	GB	US
Stage
Employee Count	9
Website	cardiatec.ai	primordialbio.com
LinkedIn	cardiatec	primordial-ai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:CARDIATEC

Cardiatec

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue